[Form 4] DBV Technologies S.A. Insider Trading Activity

Rhea-AI Filing Summary

DBV Technologies S.A. (DBVT) reported a Form 4 for its Chief Financial Officer, Virginie Boucinha, reflecting new equity compensation granted on 11/21/2025. She acquired 32,000 ordinary shares at a price of $0, representing ordinary shares underlying a restricted stock unit (RSU) award, bringing her directly held ordinary shares to 70,000. She also received an employee stock option for 192,000 ordinary shares with an exercise price of $2.9 and an expiration date of 11/21/2035. Both the RSUs and the option vest in four equal annual installments starting on November 21, 2026, contingent on her continued service with the company.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Boucinha Virginie

(Last) (First) (Middle)

C/O DBV TECHNOLOGIES S.A.

107, AVENUE DE LA REPUBLIQUE

(Street)

CHATILLON I0 92320

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DBV Technologies S.A. [ DBVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares(1)	11/21/2025		A(2)		32,000	A	$0	70,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$2.9(3)	11/21/2025		A		192,000		(4)	11/21/2035	Ordinary Shares	192,000	$0	192,000	D

Explanation of Responses:

1. The ordinary shares may be represented by American Depositary Shares, each of which currently represents five ordinary shares.

2. Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. The RSUs shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date.

3. This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.15154 to EURO 1.00 as of November 21, 2025.

4. The option shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date.

	/s/ Virginie Boucinha	11/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did DBV Technologies (DBVT) grant to its CFO?

On 11/21/2025, DBV Technologies granted its CFO, Virginie Boucinha, 32,000 ordinary shares underlying an RSU award and an option for 192,000 ordinary shares with an exercise price of $2.9.

How do the RSUs granted to the DBVT CFO vest?

The 32,000 RSUs vest in four equal annual installments starting on November 21, 2026, provided the CFO continues to provide service through each vesting date.

What are the key terms of the stock options granted to the DBVT CFO?

The employee stock option covers 192,000 ordinary shares at an exercise price of $2.9, becomes vested in four equal annual installments beginning on November 21, 2026, and expires on 11/21/2035.

How many DBV Technologies ordinary shares does the CFO own after the reported transaction?

Following the reported transaction, the CFO beneficially owns 70,000 ordinary shares directly.

How are DBV Technologies ordinary shares related to its American Depositary Shares (ADS)?

Each American Depositary Share of DBV Technologies currently represents five ordinary shares.

Is the equity held by the DBVT CFO owned directly or indirectly?

The Form 4 shows the CFO’s 70,000 ordinary shares and 192,000 options as directly owned.